Peiyong Guan

机构：Agency for Science, Technology and Research, National Cancer Centre Singapore, Genome Institute of Singapore · ORCID：0000-0001-9958-0137

发表论文 89 篇 · 总被引 2469 次 · h-index 23

代表论文

• Cholangiocarcinoma: Recent Advances in Molecular Pathobiology and Therapeutic Approaches (2024 · Cancers · 被引 42)
• Integrative multiomics enhancer activity profiling identifies therapeutic vulnerabilities in cholangiocarcinoma of different etiologies (2023 · Gut · 被引 23)
• Pharmacological modulation of RB1 activity mitigates resistance to neoadjuvant chemotherapy in locally advanced rectal cancer (2024 · Proceedings of the National Academy of Sciences · 被引 19)
• 4EBP1-mediated SLC7A11 protein synthesis restrains ferroptosis triggered by MEK inhibitors in advanced ovarian cancer (2024 · JCI Insight · 被引 18)
• Priming with DNMT Inhibitors Potentiates PD-1 Immunotherapy by Triggering Viral Mimicry in Relapsed/Refractory NK/T-cell Lymphoma (2025 · Cancer Discovery · 被引 11)
• CDC7 Inhibition Potentiates Antitumor Efficacy of PARP Inhibitor in Advanced Ovarian Cancer (2024 · Advanced Science · 被引 11)